CAM
Cormorant Asset Management’s EyePoint Pharmaceuticals EYPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $78.3M | Hold |
8,325,000
| – | – | 5.84% | 2 |
|
|
2025
Q1 | $45.1M | Hold |
8,325,000
| – | – | 3.39% | 8 |
|
|
2024
Q4 | $62M | Hold |
8,325,000
| – | – | 3.41% | 7 |
|
|
2024
Q3 | $66.5M | Hold |
8,325,000
| – | – | 3.53% | 6 |
|
|
2024
Q2 | $72.4M | Buy |
8,325,000
+1,431,765
| +21% | +$12.5M | 4.18% | 6 |
|
|
2024
Q1 | $142M | Buy |
6,893,235
+855,000
| +14% | +$17.7M | 6.25% | 2 |
|
|
2023
Q4 | $140M | Buy |
6,038,235
+2,838,235
| +89% | +$65.6M | 6.66% | 3 |
|
|
2023
Q3 | $25.6M | Hold |
3,200,000
| – | – | 1.49% | 18 |
|
|
2023
Q2 | $27.8M | Buy |
3,200,000
+2,974,935
| +1,322% | +$25.9M | 1.56% | 17 |
|
|
2023
Q1 | $662K | Buy |
+225,065
| New | +$662K | 0.04% | 66 |
|